{"gene":"GAL","run_date":"2026-06-10T01:55:20","timeline":{"discoveries":[{"year":1999,"finding":"GMAP-210 (encoded by TRIP11/GAL-GMAP locus) is a direct microtubule-binding protein that associates with a subpopulation of stable microtubules in situ. The COOH terminus binds microtubule ends while the NH2 terminus binds Golgi membranes, linking the cis-Golgi network to the minus ends of centrosome-nucleated microtubules. Overexpression induced dramatic Golgi enlargement and microtubule network perturbation, effects that required the COOH-terminal domain.","method":"In vitro microtubule-binding assay, deletion analysis, GFP-fusion overexpression, biochemical fractionation","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 1 / Strong — direct in vitro reconstitution of microtubule binding, deletion mutagenesis mapping domains, confirmed by overexpression phenotype and GFP localization","pmids":["10189370"],"is_preprint":false},{"year":2002,"finding":"Overexpression of GMAP-210 blocks both anterograde ER-to-Golgi transport (of soluble alkaline phosphatase and membrane hemagglutinin) and retrograde Golgi-to-ER transport (Shiga toxin B-subunit), causing Golgi disassembly and accumulation of Golgi proteins in vesicle clusters throughout the cell.","method":"Overexpression, transport assays (anterograde and retrograde cargo), immunofluorescence, ultrastructural analysis","journal":"Traffic (Copenhagen, Denmark)","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple cargo assays in one lab, overexpression approach (potential artifact), no rescue experiment","pmids":["12383348"],"is_preprint":false},{"year":2004,"finding":"GMAP-210 recruits gamma-tubulin-containing complexes to cis-Golgi membranes independently of microtubule polymerization and of Golgi localization. Depletion by RNAi causes extensive Golgi fragmentation. Targeting the C-terminus to mitochondria redirects gamma-tubulin to mitochondrial surfaces and redistributes mitochondria to a pericentrosomal location, indicating microtubule-anchoring activity.","method":"RNA interference (RNAi) knockdown, overexpression/targeting to mitochondria, immunofluorescence for gamma-tubulin, microtubule polymerization inhibition assays","journal":"Cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — RNAi loss-of-function with clear Golgi fragmentation phenotype plus gain-of-function retargeting experiment, replicated across multiple conditions in a high-impact venue","pmids":["15294158"],"is_preprint":false},{"year":2010,"finding":"Loss-of-function mutations in TRIP11 (encoding GMAP-210) cause lethal skeletal dysplasia (achondrogenesis type 1A) in mice and humans. GMAP-210-deficient chondrocytes show disturbed Golgi architecture, altered Golgi-mediated glycosylation, and intracellular accumulation of perlecan (but not collagen II or aggrecan), demonstrating that GMAP-210 is required for efficient glycosylation and cellular transport of select extracellular matrix proteins.","method":"Positional cloning, nonsense mutation identification, glycosylation assays in fibroblasts/chondrocytes, immunostaining for perlecan/collagen II/aggrecan, human patient sequencing","journal":"The New England journal of medicine","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic loss-of-function in mouse and replicated in 10 human patients, with biochemical glycosylation assays and cargo-specific trafficking phenotype","pmids":["20089971"],"is_preprint":false},{"year":2015,"finding":"GMAP-210 is required for efficient anterograde trafficking at both the ERGIC and the Golgi complex, and for retrograde trafficking to the ER. Co-depletion experiments showed GMAP-210 acts partially redundantly with golgin GM130 for efficient anterograde cargo delivery to the cis-Golgi.","method":"Knockdown (siRNA), anterograde/retrograde transport assays, co-depletion with GM130","journal":"Journal of cell science","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple transport assays and co-depletion epistasis in a single lab, replicates and extends earlier trafficking findings","pmids":["25717001"],"is_preprint":false},{"year":2022,"finding":"Drosophila GMAP (the ortholog of mammalian GMAP-210/TRIP11) contains a LIR motif that mediates direct interaction with Atg8a (LC3 ortholog). GMAP LIR mutant flies accumulate Golgi markers and display elongated Golgi morphology, indicating that GMAP mediates selective autophagy (Golgiphagy) to regulate Golgi morphology and size.","method":"Quantitative proteomics in Atg8a-LDS mutants, LIR motif identification, GMAP LIR mutant fly generation, Golgi marker imaging","journal":"Cell reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — proteomics identification followed by genetic LIR mutant validation with clear Golgi morphology phenotype; Drosophila ortholog, single lab","pmids":["35649355"],"is_preprint":false},{"year":1998,"finding":"GAL/GMAP immunoreactive fibers in the hippocampal formation and cortex are predominantly co-localized with dopamine beta-hydroxylase (noradrenergic marker). Treatment with 6-hydroxydopamine abolished all fibers in which GAL/GMAP and DBH co-existed, and reserpine caused marked GAL depletion, establishing that the majority of GAL/GMAP peptide in these regions is contained in noradrenergic terminals originating from the locus coeruleus.","method":"Immunofluorescence double-staining, 6-OHDA lesion, reserpine treatment","journal":"The Journal of comparative neurology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — lesion and pharmacological depletion experiments with immunohistochemistry confirming noradrenergic co-localization of GAL/GMAP","pmids":["9512271"],"is_preprint":false},{"year":1996,"finding":"Leukemia inhibitory factor (LIF) is required for the upregulation of GAL and GMAP in dorsal root ganglion neurons following peripheral axotomy. LIF-deficient mice showed a 65–70% reduction in GAL/GMAP-immunoreactive DRG neuron profiles after sciatic nerve section compared to wild-type mice, identifying LIF as a key upstream regulator of injury-induced galanin/GMAP expression.","method":"Sciatic nerve axotomy in LIF-knockout and wild-type mice, immunofluorescence quantification of GAL/GMAP-positive neuron profiles","journal":"Experimental brain research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic knockout model with quantitative immunohistochemical readout, single lab","pmids":["8951409"],"is_preprint":false},{"year":1995,"finding":"Intrathecal GMAP facilitates the baseline flexor reflex and blocks C-fiber conditioning stimulation-induced facilitation in rats with intact sciatic nerves. GMAP selectively antagonizes the reflex-facilitatory effect of substance P but not VIP. After sciatic nerve axotomy, GMAP expression is upregulated in ipsilateral DRG neurons and the blocking effect of GMAP on C-fiber-induced facilitation is significantly reduced, while the SP antagonism is lost and a VIP antagonism appears.","method":"Intrathecal peptide administration, flexor reflex electrophysiology, sciatic nerve section, immunohistochemistry","journal":"Neuropeptides","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo pharmacological and electrophysiological assays combined with axotomy model; single lab","pmids":["7603589"],"is_preprint":false},{"year":1995,"finding":"Systemic resiniferatoxin (RTX) treatment upregulates GMAP (galanin message-associated peptide) mRNA and immunoreactivity in lumbar DRG neurons, paralleling upregulation of VIP and NOS, demonstrating that capsaicin-sensitive sensory neurons regulate GMAP expression in response to neurotoxic challenge (messenger plasticity).","method":"In situ hybridization for GMAP mRNA, immunohistochemistry, subcutaneous RTX injection","journal":"Neuroreport","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single lab, correlation between toxin treatment and mRNA/peptide upregulation, no direct mechanistic dissection","pmids":["8595209"],"is_preprint":false},{"year":2022,"finding":"The galanin Gal1 receptor (Gal1R) forms functional heterotetramers with µ-opioid receptors (MOR). Within the MOR-Gal1R heterotetramer, heteromerization-dependent changes in the Gal1R homodimeric interface cause a switch in G-protein coupling from inhibitory Gi to stimulatory Gs proteins, while the MOR homodimer remains coupled to Gi, enabling canonical Gs-Gi antagonism at the adenylyl cyclase level.","method":"Peptide-interfering approach, total internal reflection fluorescence microscopy, co-immunoprecipitation, BRET/FRET biophysical assays, cAMP assays","journal":"Pharmacological research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple biophysical and biochemical methods in a single lab; novel mechanistic finding about G-protein coupling switch upon heterotetramerization","pmids":["35750299"],"is_preprint":false}],"current_model":"GMAP-210 (encoded by TRIP11, a product of the GAL/GAL-GMAP locus) is a cis-Golgi-associated coiled-coil protein whose NH2-terminus anchors it to Golgi membranes and whose COOH-terminus binds microtubule minus ends and recruits gamma-tubulin complexes, thereby tethering the cis-Golgi network to centrosome-nucleated microtubules, maintaining Golgi ribbon integrity, supporting bidirectional ER-Golgi vesicular trafficking, and regulating Golgi turnover via a LIR-motif-dependent selective autophagy interaction with Atg8/LC3; loss-of-function mutations cause achondrogenesis type 1A due to impaired glycosylation and selective intracellular cargo accumulation in chondrocytes; the GAL/GMAP neuropeptide precursor co-localizes with noradrenergic neurons in the locus coeruleus and hippocampal terminals, is upregulated after peripheral axotomy via LIF signaling, modulates spinal nociceptive transmission, and its receptor Gal1R can switch G-protein coupling from Gi to Gs upon forming heterotetramers with µ-opioid receptors."},"narrative":{"mechanistic_narrative":"The GAL/GMAP locus is bicistronic in function within this corpus, encoding both the Golgi-associated coiled-coil protein GMAP-210 (TRIP11) and the galanin/GMAP neuropeptide precursor [PMID:10189370, PMID:9512271]. GMAP-210 is a microtubule-binding protein that tethers the cis-Golgi network to centrosome-nucleated microtubules: its COOH-terminus binds microtubule minus ends while its NH2-terminus anchors to Golgi membranes, and the C-terminus recruits gamma-tubulin complexes to Golgi membranes independently of microtubule polymerization [PMID:10189370, PMID:15294158]. Through this anchoring it maintains Golgi ribbon integrity—depletion fragments the Golgi while overexpression enlarges and disassembles it—and supports bidirectional ER-Golgi vesicular trafficking, acting partially redundantly with GM130 for anterograde cargo delivery to the cis-Golgi [PMID:12383348, PMID:15294158, PMID:25717001]. A LIR motif in GMAP mediates direct interaction with Atg8/LC3 to drive selective autophagy of the Golgi (Golgiphagy), regulating Golgi size and morphology [PMID:35649355]. Loss-of-function mutations in TRIP11 cause achondrogenesis type 1A, with chondrocytes showing disturbed Golgi architecture, altered glycosylation, and selective intracellular accumulation of perlecan [PMID:20089971]. Separately, the galanin/GMAP neuropeptide is concentrated in noradrenergic locus coeruleus terminals projecting to hippocampus and cortex, is upregulated in sensory neurons after peripheral axotomy via LIF signaling, and modulates spinal nociceptive transmission [PMID:9512271, PMID:8951409, PMID:7603589]; its receptor Gal1R switches G-protein coupling from Gi to Gs upon forming heterotetramers with µ-opioid receptors [PMID:35750299].","teleology":[{"year":1999,"claim":"Established the core biochemical activity of GMAP-210 by showing it physically bridges the cis-Golgi to microtubules, defining the molecular basis for Golgi positioning.","evidence":"In vitro microtubule-binding assay with deletion analysis and GFP-fusion overexpression","pmids":["10189370"],"confidence":"High","gaps":["Overexpression phenotype may not reflect endogenous stoichiometry","Did not address how membrane and microtubule binding are coordinated in vivo"]},{"year":2002,"claim":"Linked GMAP-210 dosage to vesicular transport by showing its overexpression blocks both anterograde and retrograde ER-Golgi traffic, implicating it in trafficking beyond static tethering.","evidence":"Overexpression with multiple cargo transport assays and ultrastructural analysis","pmids":["12383348"],"confidence":"Medium","gaps":["Overexpression approach risks dominant-negative artifact","No rescue or loss-of-function complement"]},{"year":2004,"claim":"Defined GMAP-210 as a microtubule-anchoring factor that recruits gamma-tubulin to the Golgi, explaining how it nucleates/anchors microtubules at the Golgi surface; RNAi depletion confirmed it is required for Golgi integrity.","evidence":"RNAi knockdown plus gain-of-function mitochondrial retargeting with gamma-tubulin immunofluorescence","pmids":["15294158"],"confidence":"High","gaps":["Direct gamma-tubulin complex binding interface not mapped","Relationship between gamma-tubulin recruitment and trafficking function unresolved"]},{"year":2010,"claim":"Connected GMAP-210 loss to human disease, showing TRIP11 mutations cause achondrogenesis type 1A through Golgi-dependent glycosylation defects and cargo-selective trafficking failure.","evidence":"Positional cloning, mouse knockout, human patient sequencing, glycosylation and cargo-specific immunostaining assays","pmids":["20089971"],"confidence":"High","gaps":["Why perlecan but not collagen II/aggrecan is selectively retained is unexplained","Mechanism linking Golgi architecture loss to glycosylation defect not detailed"]},{"year":2015,"claim":"Refined GMAP-210's trafficking role by demonstrating it functions at both ERGIC and Golgi and acts redundantly with GM130, clarifying the network of golgins supporting cargo delivery.","evidence":"siRNA knockdown with co-depletion epistasis and transport assays","pmids":["25717001"],"confidence":"Medium","gaps":["Degree of functional overlap with other golgins not exhaustively tested","Single-lab transport assays"]},{"year":2022,"claim":"Identified a new regulatory mechanism for Golgi homeostasis by showing GMAP uses a LIR motif to drive selective autophagy of the Golgi (Golgiphagy).","evidence":"Atg8a-LDS proteomics and GMAP LIR mutant fly generation with Golgi marker imaging","pmids":["35649355"],"confidence":"Medium","gaps":["Demonstrated in Drosophila ortholog; mammalian conservation not shown in this corpus","Trigger and physiological context of Golgiphagy unknown"]},{"year":1996,"claim":"Identified LIF as an upstream regulator of injury-induced galanin/GMAP expression, framing the neuropeptide arm as part of a regulated nerve-injury response.","evidence":"Sciatic nerve axotomy in LIF-knockout vs wild-type mice with immunofluorescence quantification","pmids":["8951409"],"confidence":"Medium","gaps":["Downstream signaling from LIF to GAL/GMAP transcription not mapped","Single-lab knockout model"]},{"year":1998,"claim":"Localized the galanin/GMAP neuropeptide to noradrenergic locus coeruleus terminals in hippocampus and cortex, establishing its anatomical neurotransmitter context.","evidence":"Immunofluorescence double-staining with 6-OHDA lesion and reserpine depletion","pmids":["9512271"],"confidence":"Medium","gaps":["Functional consequence of co-release with noradrenaline not addressed","Receptor mediating effects in these regions not identified here"]},{"year":1995,"claim":"Characterized the GMAP neuropeptide's modulation of spinal nociception and its plasticity after nerve injury, showing it antagonizes substance P-driven reflex facilitation and shifts specificity after axotomy.","evidence":"Intrathecal peptide administration, flexor reflex electrophysiology, axotomy and immunohistochemistry; plus RTX-induced mRNA/peptide upregulation by in situ hybridization","pmids":["7603589","8595209"],"confidence":"Medium","gaps":["Receptor mediating GMAP's spinal effects not identified","RTX upregulation is correlative without mechanistic dissection"]},{"year":2022,"claim":"Revealed that the galanin Gal1 receptor reverses its G-protein output by switching from Gi to Gs upon heterotetramerizing with µ-opioid receptors, providing a mechanism for galanin-opioid crosstalk.","evidence":"Peptide-interfering approach, TIRF microscopy, co-IP, BRET/FRET and cAMP assays","pmids":["35750299"],"confidence":"Medium","gaps":["Physiological/in vivo relevance of the coupling switch not established","Single-lab biophysical characterization"]},{"year":null,"claim":"How the two distinct functional outputs of the GAL/GMAP locus—the Golgi-tethering GMAP-210 protein and the secreted galanin/GMAP neuropeptide—are co-regulated or whether they share any mechanistic interplay remains unresolved.","evidence":"","pmids":[],"confidence":"Low","gaps":["No corpus finding links the trafficking and neuropeptide functions mechanistically","Conservation of Golgiphagy in mammals untested","In vivo significance of Gal1R-MOR coupling switch unknown"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0008092","term_label":"cytoskeletal protein binding","supporting_discovery_ids":[0,2]},{"term_id":"GO:0060089","term_label":"molecular transducer activity","supporting_discovery_ids":[10]}],"localization":[{"term_id":"GO:0005794","term_label":"Golgi apparatus","supporting_discovery_ids":[0,1,2]},{"term_id":"GO:0005815","term_label":"microtubule organizing center","supporting_discovery_ids":[0,2]}],"pathway":[{"term_id":"R-HSA-5653656","term_label":"Vesicle-mediated transport","supporting_discovery_ids":[1,4]},{"term_id":"R-HSA-9612973","term_label":"Autophagy","supporting_discovery_ids":[5]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[10]}],"complexes":["MOR-Gal1R heterotetramer"],"partners":["GM130","ATG8A","GAMMA-TUBULIN","MOR"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P22466","full_name":"Galanin peptides","aliases":[],"length_aa":123,"mass_kda":13.3,"function":"Endocrine hormone of the central and peripheral nervous systems that binds and activates the G protein-coupled receptors GALR1, GALR2, and GALR3. This small neuropeptide may regulate diverse physiologic functions including contraction of smooth muscle of the gastrointestinal and genitourinary tract, growth hormone and insulin release and adrenal secretion","subcellular_location":"Secreted","url":"https://www.uniprot.org/uniprotkb/P22466/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/GAL","classification":"Not Classified","n_dependent_lines":18,"n_total_lines":1208,"dependency_fraction":0.014900662251655629},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/GAL","total_profiled":1310},"omim":[{"mim_id":"620776","title":"THROMBOCYTOPENIA 13, SYNDROMIC; THC13","url":"https://www.omim.org/entry/620776"},{"mim_id":"619624","title":"LEMUR TYROSINE KINASE 3; LMTK3","url":"https://www.omim.org/entry/619624"},{"mim_id":"619600","title":"AMINOPEPTIDASE O; AOPEP","url":"https://www.omim.org/entry/619600"},{"mim_id":"619287","title":"COILED-COIL DOMAIN-CONTAINING PROTEIN 66; CCDC66","url":"https://www.omim.org/entry/619287"},{"mim_id":"619246","title":"SPEXIN HORMONE; SPX","url":"https://www.omim.org/entry/619246"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Golgi apparatus","reliability":"Approved"},{"location":"Vesicles","reliability":"Additional"}],"tissue_specificity":"Tissue enriched","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"pituitary gland","ntpm":957.4}],"url":"https://www.proteinatlas.org/search/GAL"},"hgnc":{"alias_symbol":["GMAP","GAL-GMAP","GLNN"],"prev_symbol":["GALN"]},"alphafold":{"accession":"P22466","domains":[{"cath_id":"-","chopping":"3-111","consensus_level":"medium","plddt":64.2846,"start":3,"end":111}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P22466","model_url":"https://alphafold.ebi.ac.uk/files/AF-P22466-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P22466-F1-predicted_aligned_error_v6.png","plddt_mean":66.56},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=GAL","jax_strain_url":"https://www.jax.org/strain/search?query=GAL"},"sequence":{"accession":"P22466","fasta_url":"https://rest.uniprot.org/uniprotkb/P22466.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P22466/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P22466"}},"corpus_meta":[{"pmid":"15728110","id":"PMC_15728110","title":"GMAP: a genomic mapping and alignment program for mRNA and EST sequences.","date":"2005","source":"Bioinformatics (Oxford, England)","url":"https://pubmed.ncbi.nlm.nih.gov/15728110","citation_count":1687,"is_preprint":false},{"pmid":"27512904","id":"PMC_27512904","title":"Fap2 Mediates Fusobacterium nucleatum Colorectal Adenocarcinoma Enrichment by Binding to Tumor-Expressed Gal-GalNAc.","date":"2016","source":"Cell host & microbe","url":"https://pubmed.ncbi.nlm.nih.gov/27512904","citation_count":673,"is_preprint":false},{"pmid":"7601342","id":"PMC_7601342","title":"Transcriptional regulation in the yeast GAL gene family: a complex genetic network.","date":"1995","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/7601342","citation_count":327,"is_preprint":false},{"pmid":"27008021","id":"PMC_27008021","title":"GMAP and GSNAP for Genomic Sequence Alignment: Enhancements to Speed, Accuracy, and Functionality.","date":"2016","source":"Methods in molecular biology (Clifton, N.J.)","url":"https://pubmed.ncbi.nlm.nih.gov/27008021","citation_count":313,"is_preprint":false},{"pmid":"16266320","id":"PMC_16266320","title":"The alpha-gal epitope and the anti-Gal antibody in xenotransplantation and in cancer immunotherapy.","date":"2005","source":"Immunology and cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/16266320","citation_count":269,"is_preprint":false},{"pmid":"25747720","id":"PMC_25747720","title":"The alpha-gal story: lessons learned from connecting the dots.","date":"2015","source":"The Journal of allergy and clinical immunology","url":"https://pubmed.ncbi.nlm.nih.gov/25747720","citation_count":257,"is_preprint":false},{"pmid":"7532618","id":"PMC_7532618","title":"Gal alpha (1,3)Gal, the major xenoantigen(s) recognised in pigs by human natural antibodies.","date":"1994","source":"Immunological reviews","url":"https://pubmed.ncbi.nlm.nih.gov/7532618","citation_count":253,"is_preprint":false},{"pmid":"23578170","id":"PMC_23578170","title":"Anti-Gal: an abundant human natural antibody of multiple pathogeneses and clinical benefits.","date":"2013","source":"Immunology","url":"https://pubmed.ncbi.nlm.nih.gov/23578170","citation_count":185,"is_preprint":false},{"pmid":"15294158","id":"PMC_15294158","title":"GMAP-210 recruits gamma-tubulin complexes to cis-Golgi membranes and is required for Golgi ribbon formation.","date":"2004","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/15294158","citation_count":183,"is_preprint":false},{"pmid":"9512271","id":"PMC_9512271","title":"Galanin/GMAP- and NPY-like immunoreactivities in locus coeruleus and noradrenergic nerve terminals in the hippocampal formation and cortex with notes on the galanin-R1 and -R2 receptors.","date":"1998","source":"The Journal of comparative neurology","url":"https://pubmed.ncbi.nlm.nih.gov/9512271","citation_count":161,"is_preprint":false},{"pmid":"2862582","id":"PMC_2862582","title":"Gal-Gal binding and hemolysin phenotypes and genotypes associated with uropathogenic Escherichia coli.","date":"1985","source":"The New England journal of medicine","url":"https://pubmed.ncbi.nlm.nih.gov/2862582","citation_count":150,"is_preprint":false},{"pmid":"10189370","id":"PMC_10189370","title":"GMAP-210, A cis-Golgi network-associated protein, is a minus end microtubule-binding protein.","date":"1999","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/10189370","citation_count":147,"is_preprint":false},{"pmid":"15381776","id":"PMC_15381776","title":"Parallel inactivation of multiple GAL pathway genes and ecological diversification in yeasts.","date":"2004","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/15381776","citation_count":146,"is_preprint":false},{"pmid":"8951409","id":"PMC_8951409","title":"Influence of leukemia inhibitory factor on galanin/GMAP and neuropeptide Y expression in mouse primary sensory neurons after axotomy.","date":"1996","source":"Experimental brain research","url":"https://pubmed.ncbi.nlm.nih.gov/8951409","citation_count":126,"is_preprint":false},{"pmid":"20089971","id":"PMC_20089971","title":"Lethal skeletal dysplasia in mice and humans lacking the golgin GMAP-210.","date":"2010","source":"The New England journal of medicine","url":"https://pubmed.ncbi.nlm.nih.gov/20089971","citation_count":115,"is_preprint":false},{"pmid":"18358727","id":"PMC_18358727","title":"Trivalent, Gal/GalNAc-containing ligands designed for the asialoglycoprotein receptor.","date":"2008","source":"Bioorganic & medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/18358727","citation_count":109,"is_preprint":false},{"pmid":"20479238","id":"PMC_20479238","title":"Multiple GAL pathway gene clusters evolved independently and by different mechanisms in fungi.","date":"2010","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/20479238","citation_count":108,"is_preprint":false},{"pmid":"31214181","id":"PMC_31214181","title":"Environmental and Molecular Drivers of the α-Gal Syndrome.","date":"2019","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/31214181","citation_count":97,"is_preprint":false},{"pmid":"2744457","id":"PMC_2744457","title":"DNA bending by negative regulatory proteins: Gal and Lac repressors.","date":"1989","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/2744457","citation_count":92,"is_preprint":false},{"pmid":"16144463","id":"PMC_16144463","title":"Presence and elimination of the xenoantigen gal (alpha1, 3) gal in tissue-engineered heart valves.","date":"2005","source":"Tissue engineering","url":"https://pubmed.ncbi.nlm.nih.gov/16144463","citation_count":77,"is_preprint":false},{"pmid":"39018876","id":"PMC_39018876","title":"Graveoline attenuates D-GalN/LPS-induced acute liver injury via inhibition of JAK1/STAT3 signaling pathway.","date":"2024","source":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie","url":"https://pubmed.ncbi.nlm.nih.gov/39018876","citation_count":76,"is_preprint":false},{"pmid":"6715281","id":"PMC_6715281","title":"Sequence of the Saccharomyces GAL region and its transcription in vivo.","date":"1984","source":"Journal of bacteriology","url":"https://pubmed.ncbi.nlm.nih.gov/6715281","citation_count":74,"is_preprint":false},{"pmid":"9098067","id":"PMC_9098067","title":"Transcription of glutamine synthetase genes (glnA and glnN) from the cyanobacterium Synechocystis sp. strain PCC 6803 is differently regulated in response to nitrogen availability.","date":"1997","source":"Journal of bacteriology","url":"https://pubmed.ncbi.nlm.nih.gov/9098067","citation_count":72,"is_preprint":false},{"pmid":"26531137","id":"PMC_26531137","title":"Characteristics of α-Gal epitope, anti-Gal antibody, α1,3 galactosyltransferase and its clinical exploitation (Review).","date":"2015","source":"International journal of molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/26531137","citation_count":63,"is_preprint":false},{"pmid":"18001501","id":"PMC_18001501","title":"N-GAL: diagnosing AKI as soon as possible.","date":"2007","source":"Critical care (London, England)","url":"https://pubmed.ncbi.nlm.nih.gov/18001501","citation_count":60,"is_preprint":false},{"pmid":"10450874","id":"PMC_10450874","title":"Expression of the galanin receptor subtype Gal-R2 mRNA in the rat hypothalamus.","date":"1999","source":"Journal of chemical neuroanatomy","url":"https://pubmed.ncbi.nlm.nih.gov/10450874","citation_count":59,"is_preprint":false},{"pmid":"28282576","id":"PMC_28282576","title":"Antioxidation, anti-inflammation and anti-apoptosis by paeonol in LPS/d-GalN-induced acute liver failure in mice.","date":"2017","source":"International immunopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/28282576","citation_count":59,"is_preprint":false},{"pmid":"8557707","id":"PMC_8557707","title":"Genomic organization and chromosomal mapping of the Gal beta 1,3GalNAc/Gal beta 1,4GlcNAc alpha 2,3-sialyltransferase.","date":"1996","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8557707","citation_count":59,"is_preprint":false},{"pmid":"7906687","id":"PMC_7906687","title":"A new type of glutamine synthetase in cyanobacteria: the protein encoded by the glnN gene supports nitrogen assimilation in Synechocystis sp. strain PCC 6803.","date":"1994","source":"Journal of bacteriology","url":"https://pubmed.ncbi.nlm.nih.gov/7906687","citation_count":53,"is_preprint":false},{"pmid":"22639266","id":"PMC_22639266","title":"Detection of β-galactosidase activity: X-gal staining.","date":"2012","source":"Methods in molecular biology (Clifton, N.J.)","url":"https://pubmed.ncbi.nlm.nih.gov/22639266","citation_count":52,"is_preprint":false},{"pmid":"31053502","id":"PMC_31053502","title":"Alpha-Gal-containing biologics and anaphylaxis.","date":"2019","source":"Allergology international : official journal of the Japanese Society of Allergology","url":"https://pubmed.ncbi.nlm.nih.gov/31053502","citation_count":49,"is_preprint":false},{"pmid":"35386980","id":"PMC_35386980","title":"The α-Gal Syndrome and Potential Mechanisms.","date":"2021","source":"Frontiers in allergy","url":"https://pubmed.ncbi.nlm.nih.gov/35386980","citation_count":49,"is_preprint":false},{"pmid":"12383348","id":"PMC_12383348","title":"The overexpression of GMAP-210 blocks anterograde and retrograde transport between the ER and the Golgi apparatus.","date":"2002","source":"Traffic (Copenhagen, Denmark)","url":"https://pubmed.ncbi.nlm.nih.gov/12383348","citation_count":49,"is_preprint":false},{"pmid":"35149838","id":"PMC_35149838","title":"LncRNA GAL promotes colorectal cancer liver metastasis through stabilizing GLUT1.","date":"2022","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/35149838","citation_count":49,"is_preprint":false},{"pmid":"22360754","id":"PMC_22360754","title":"The effect of Gal expression on pig cells on the human T-cell xenoresponse.","date":"2012","source":"Xenotransplantation","url":"https://pubmed.ncbi.nlm.nih.gov/22360754","citation_count":49,"is_preprint":false},{"pmid":"36134173","id":"PMC_36134173","title":"The Meat of the Matter: Understanding and Managing Alpha-Gal Syndrome.","date":"2022","source":"ImmunoTargets and therapy","url":"https://pubmed.ncbi.nlm.nih.gov/36134173","citation_count":47,"is_preprint":false},{"pmid":"15695361","id":"PMC_15695361","title":"Gal80 dimerization and the yeast GAL gene switch.","date":"2005","source":"Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/15695361","citation_count":47,"is_preprint":false},{"pmid":"18772342","id":"PMC_18772342","title":"Differential roles of JNK in ConA/GalN and ConA-induced liver injury in mice.","date":"2008","source":"The American journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/18772342","citation_count":44,"is_preprint":false},{"pmid":"21848538","id":"PMC_21848538","title":"Gal/non-Gal antigens in pig tissues and human non-Gal antibodies in the GalT-KO era.","date":"2011","source":"Xenotransplantation","url":"https://pubmed.ncbi.nlm.nih.gov/21848538","citation_count":43,"is_preprint":false},{"pmid":"25717001","id":"PMC_25717001","title":"The golgin GMAP-210 is required for efficient membrane trafficking in the early secretory pathway.","date":"2015","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/25717001","citation_count":42,"is_preprint":false},{"pmid":"11144962","id":"PMC_11144962","title":"The X-gal caution in neural transplantation studies.","date":"2000","source":"Cell transplantation","url":"https://pubmed.ncbi.nlm.nih.gov/11144962","citation_count":42,"is_preprint":false},{"pmid":"9726228","id":"PMC_9726228","title":"Expression of Gal alpha(1,3)gal on neonatal porcine islet beta-cells and susceptibility to human antibody/complement lysis.","date":"1998","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/9726228","citation_count":42,"is_preprint":false},{"pmid":"35729734","id":"PMC_35729734","title":"Orientin Attenuated d-GalN/LPS-Induced Liver Injury through the Inhibition of Oxidative Stress via Nrf2/Keap1 Pathway.","date":"2022","source":"Journal of agricultural and food chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/35729734","citation_count":39,"is_preprint":false},{"pmid":"22146315","id":"PMC_22146315","title":"Induced anti-non gal antibodies in human xenograft recipients.","date":"2012","source":"Transplantation","url":"https://pubmed.ncbi.nlm.nih.gov/22146315","citation_count":38,"is_preprint":false},{"pmid":"29301066","id":"PMC_29301066","title":"An Expanded Heterologous GAL Promoter Collection for Diauxie-Inducible Expression in Saccharomyces cerevisiae.","date":"2018","source":"ACS synthetic biology","url":"https://pubmed.ncbi.nlm.nih.gov/29301066","citation_count":37,"is_preprint":false},{"pmid":"8595209","id":"PMC_8595209","title":"Increased levels of GMAP, VIP and nitric oxide synthase, and their mRNAs, in lumbar dorsal root ganglia of the rat following systemic resiniferatoxin treatment.","date":"1995","source":"Neuroreport","url":"https://pubmed.ncbi.nlm.nih.gov/8595209","citation_count":36,"is_preprint":false},{"pmid":"15289461","id":"PMC_15289461","title":"DNA trajectory in the Gal repressosome.","date":"2004","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/15289461","citation_count":36,"is_preprint":false},{"pmid":"30134043","id":"PMC_30134043","title":"Deletion of caveolin-1 attenuates LPS/GalN-induced acute liver injury in mice.","date":"2018","source":"Journal of cellular and molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/30134043","citation_count":35,"is_preprint":false},{"pmid":"31402917","id":"PMC_31402917","title":"Gal-3BP Negatively Regulates NF-κB Signaling by Inhibiting the Activation of TAK1.","date":"2019","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/31402917","citation_count":35,"is_preprint":false},{"pmid":"25400741","id":"PMC_25400741","title":"Pretreatment of lipopolysaccharide (LPS) ameliorates D-GalN/LPS induced acute liver failure through TLR4 signaling pathway.","date":"2014","source":"International journal of clinical and experimental pathology","url":"https://pubmed.ncbi.nlm.nih.gov/25400741","citation_count":35,"is_preprint":false},{"pmid":"31763668","id":"PMC_31763668","title":"Gal-3 is a potential biomarker for spinal cord injury and Gal-3 deficiency attenuates neuroinflammation through ROS/TXNIP/NLRP3 signaling pathway.","date":"2019","source":"Bioscience reports","url":"https://pubmed.ncbi.nlm.nih.gov/31763668","citation_count":35,"is_preprint":false},{"pmid":"32948455","id":"PMC_32948455","title":"α-Gal-Based Vaccines: Advances, Opportunities, and Perspectives.","date":"2020","source":"Trends in parasitology","url":"https://pubmed.ncbi.nlm.nih.gov/32948455","citation_count":34,"is_preprint":false},{"pmid":"17991149","id":"PMC_17991149","title":"Gal alpha(1-3)Gal expression of the cornea in vitro, in vivo and in xenotransplantation.","date":"2007","source":"Xenotransplantation","url":"https://pubmed.ncbi.nlm.nih.gov/17991149","citation_count":34,"is_preprint":false},{"pmid":"33986260","id":"PMC_33986260","title":"Prevention of D-GalN/LPS-induced ALI by 18β-glycyrrhetinic acid through PXR-mediated inhibition of autophagy degradation.","date":"2021","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/33986260","citation_count":34,"is_preprint":false},{"pmid":"10986271","id":"PMC_10986271","title":"The Synechococcus strain PCC 7942 glnN product (glutamine synthetase III) helps recovery from prolonged nitrogen chlorosis.","date":"2000","source":"Journal of bacteriology","url":"https://pubmed.ncbi.nlm.nih.gov/10986271","citation_count":34,"is_preprint":false},{"pmid":"14596799","id":"PMC_14596799","title":"\"Antiparallel\" DNA loop in gal repressosome visualized by atomic force microscopy.","date":"2003","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/14596799","citation_count":34,"is_preprint":false},{"pmid":"9325090","id":"PMC_9325090","title":"Repression and activation of promoter-bound RNA polymerase activity by Gal repressor.","date":"1997","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/9325090","citation_count":34,"is_preprint":false},{"pmid":"4942917","id":"PMC_4942917","title":"Isolation of the gal repressor.","date":"1971","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/4942917","citation_count":33,"is_preprint":false},{"pmid":"33009122","id":"PMC_33009122","title":"'Doc, will I ever eat steak again?': diagnosis and management of alpha-gal syndrome.","date":"2020","source":"Current opinion in pediatrics","url":"https://pubmed.ncbi.nlm.nih.gov/33009122","citation_count":33,"is_preprint":false},{"pmid":"26211586","id":"PMC_26211586","title":"Cerium oxide nanoparticles alleviate oxidative stress and decreases Nrf-2/HO-1 in D-GALN/LPS induced hepatotoxicity.","date":"2015","source":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie","url":"https://pubmed.ncbi.nlm.nih.gov/26211586","citation_count":33,"is_preprint":false},{"pmid":"8839767","id":"PMC_8839767","title":"Gal-GalNAc: a biomarker of colon carcinogenesis.","date":"1996","source":"Histology and histopathology","url":"https://pubmed.ncbi.nlm.nih.gov/8839767","citation_count":33,"is_preprint":false},{"pmid":"22065336","id":"PMC_22065336","title":"Triptolide attenuate the oxidative stress induced by LPS/D-GalN in mice.","date":"2012","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/22065336","citation_count":32,"is_preprint":false},{"pmid":"35836757","id":"PMC_35836757","title":"Ginsenoside Rb1 Reduces D-GalN/LPS-induced Acute Liver Injury by Regulating TLR4/NF-κB Signaling and NLRP3 Inflammasome.","date":"2021","source":"Journal of clinical and translational hepatology","url":"https://pubmed.ncbi.nlm.nih.gov/35836757","citation_count":30,"is_preprint":false},{"pmid":"35750299","id":"PMC_35750299","title":"Preferential Gs protein coupling of the galanin Gal1 receptor in the µ-opioid-Gal1 receptor heterotetramer.","date":"2022","source":"Pharmacological research","url":"https://pubmed.ncbi.nlm.nih.gov/35750299","citation_count":29,"is_preprint":false},{"pmid":"22069473","id":"PMC_22069473","title":"Complement and the alternative pathway play an important role in LPS/D-GalN-induced fulminant hepatic failure.","date":"2011","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/22069473","citation_count":29,"is_preprint":false},{"pmid":"32267656","id":"PMC_32267656","title":"LAG-3 and GAL-3 in Endometrial Carcinoma: Emerging Candidates for Immunotherapy.","date":"2020","source":"International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists","url":"https://pubmed.ncbi.nlm.nih.gov/32267656","citation_count":29,"is_preprint":false},{"pmid":"34926322","id":"PMC_34926322","title":"Alpha-Gal Syndrome: Involvement of Amblyomma americanum α-D-Galactosidase and β-1,4 Galactosyltransferase Enzymes in α-Gal Metabolism.","date":"2021","source":"Frontiers in cellular and infection microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/34926322","citation_count":29,"is_preprint":false},{"pmid":"31795213","id":"PMC_31795213","title":"FOXD1 and Gal-3 Form a Positive Regulatory Loop to Regulate Lung Cancer Aggressiveness.","date":"2019","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/31795213","citation_count":29,"is_preprint":false},{"pmid":"31792144","id":"PMC_31792144","title":"Screening Bacterial Colonies Using X-Gal and IPTG: α-Complementation.","date":"2019","source":"Cold Spring Harbor protocols","url":"https://pubmed.ncbi.nlm.nih.gov/31792144","citation_count":28,"is_preprint":false},{"pmid":"32027409","id":"PMC_32027409","title":"Topical α-gal nanoparticles accelerate diabetic wound healing.","date":"2020","source":"Experimental dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/32027409","citation_count":28,"is_preprint":false},{"pmid":"27420055","id":"PMC_27420055","title":"BML-111 Protected LPS/D-GalN-Induced Acute Liver Injury in Rats.","date":"2016","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/27420055","citation_count":28,"is_preprint":false},{"pmid":"17227553","id":"PMC_17227553","title":"Gal knockout and beyond.","date":"2007","source":"American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons","url":"https://pubmed.ncbi.nlm.nih.gov/17227553","citation_count":27,"is_preprint":false},{"pmid":"26352381","id":"PMC_26352381","title":"Identification and Characterization of GAL-021 as a Novel Breathing Control Modulator.","date":"2015","source":"Anesthesiology","url":"https://pubmed.ncbi.nlm.nih.gov/26352381","citation_count":27,"is_preprint":false},{"pmid":"19895316","id":"PMC_19895316","title":"Identification of alpha-Gal and non-Gal epitopes in pig corneal endothelial cells and keratocytes by using mass spectrometry.","date":"2009","source":"Current eye research","url":"https://pubmed.ncbi.nlm.nih.gov/19895316","citation_count":26,"is_preprint":false},{"pmid":"7603589","id":"PMC_7603589","title":"Peripheral axotomy increases the expression of galanin message-associated peptide (GMAP) in dorsal root ganglion cells and alters the effects of intrathecal GMAP on the flexor reflex in the rat.","date":"1995","source":"Neuropeptides","url":"https://pubmed.ncbi.nlm.nih.gov/7603589","citation_count":25,"is_preprint":false},{"pmid":"32431618","id":"PMC_32431618","title":"Quercetin Attenuates d-GaLN-Induced L02 Cell Damage by Suppressing Oxidative Stress and Mitochondrial Apoptosis via Inhibition of HMGB1.","date":"2020","source":"Frontiers in pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/32431618","citation_count":25,"is_preprint":false},{"pmid":"34208966","id":"PMC_34208966","title":"Probiotic Bacteria with High Alpha-Gal Content Protect Zebrafish against Mycobacteriosis.","date":"2021","source":"Pharmaceuticals (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/34208966","citation_count":25,"is_preprint":false},{"pmid":"15943776","id":"PMC_15943776","title":"Reducing Gal expression on the pig organ - a retrospective review.","date":"2005","source":"Xenotransplantation","url":"https://pubmed.ncbi.nlm.nih.gov/15943776","citation_count":23,"is_preprint":false},{"pmid":"28572155","id":"PMC_28572155","title":"Elastin receptor (S-gal) occupancy by elastin peptides modulates T-cell response during murine emphysema.","date":"2017","source":"American journal of physiology. Lung cellular and molecular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/28572155","citation_count":23,"is_preprint":false},{"pmid":"28901440","id":"PMC_28901440","title":"Autophagy and ER stress in LPS/GalN‑induced acute liver injury.","date":"2017","source":"Molecular medicine reports","url":"https://pubmed.ncbi.nlm.nih.gov/28901440","citation_count":23,"is_preprint":false},{"pmid":"35216164","id":"PMC_35216164","title":"Association of Tim-3/Gal-9 Axis with NLRC4 Inflammasome in Glioma Malignancy: Tim-3/Gal-9 Induce the NLRC4 Inflammasome.","date":"2022","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/35216164","citation_count":23,"is_preprint":false},{"pmid":"28689811","id":"PMC_28689811","title":"AMPK activation ameliorates D-GalN/LPS-induced acute liver failure by upregulating Foxo3A to induce autophagy.","date":"2017","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/28689811","citation_count":23,"is_preprint":false},{"pmid":"9988484","id":"PMC_9988484","title":"Nitrogen control of the glnN gene that codes for GS type III, the only glutamine synthetase in the cyanobacterium Pseudanabaena sp. PCC 6903.","date":"1998","source":"Molecular microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/9988484","citation_count":22,"is_preprint":false},{"pmid":"33378967","id":"PMC_33378967","title":"Research progress on the role of gal-3 in cardio/cerebrovascular diseases.","date":"2020","source":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie","url":"https://pubmed.ncbi.nlm.nih.gov/33378967","citation_count":22,"is_preprint":false},{"pmid":"30648945","id":"PMC_30648945","title":"Gal power: the diverse roles of galectins in regulating viral infections.","date":"2019","source":"The Journal of general virology","url":"https://pubmed.ncbi.nlm.nih.gov/30648945","citation_count":22,"is_preprint":false},{"pmid":"32473572","id":"PMC_32473572","title":"The improvement effect of gastrodin on LPS/GalN-induced fulminant hepatitis via inhibiting inflammation and apoptosis and restoring autophagy.","date":"2020","source":"International immunopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/32473572","citation_count":22,"is_preprint":false},{"pmid":"15930442","id":"PMC_15930442","title":"Human galanin (GAL) and galanin 1 receptor (GALR1) variations are not involved in fat intake and early onset obesity.","date":"2005","source":"The Journal of nutrition","url":"https://pubmed.ncbi.nlm.nih.gov/15930442","citation_count":22,"is_preprint":false},{"pmid":"27181579","id":"PMC_27181579","title":"Amoebiasis vaccine development: A snapshot on E. histolytica with emphasis on perspectives of Gal/GalNAc lectin.","date":"2016","source":"International journal of biological macromolecules","url":"https://pubmed.ncbi.nlm.nih.gov/27181579","citation_count":22,"is_preprint":false},{"pmid":"38390396","id":"PMC_38390396","title":"Tick bite-induced alpha-gal syndrome and immunologic responses in an alpha-gal deficient murine model.","date":"2024","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/38390396","citation_count":21,"is_preprint":false},{"pmid":"35649355","id":"PMC_35649355","title":"GMAP is an Atg8a-interacting protein that regulates Golgi turnover in Drosophila.","date":"2022","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/35649355","citation_count":21,"is_preprint":false},{"pmid":"32628573","id":"PMC_32628573","title":"Alpha-gal syndrome: challenges to understanding sensitization and clinical reactions to alpha-gal.","date":"2020","source":"Expert review of molecular diagnostics","url":"https://pubmed.ncbi.nlm.nih.gov/32628573","citation_count":21,"is_preprint":false},{"pmid":"33377532","id":"PMC_33377532","title":"Oridonin alleviates d-GalN/LPS-induced acute liver injury by inhibiting NLRP3 inflammasome.","date":"2020","source":"Drug development research","url":"https://pubmed.ncbi.nlm.nih.gov/33377532","citation_count":21,"is_preprint":false},{"pmid":"29331040","id":"PMC_29331040","title":"Jun, Gal, Cd74, and C1qb as potential indicator for neuropathic pain.","date":"2018","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/29331040","citation_count":21,"is_preprint":false},{"pmid":"28586153","id":"PMC_28586153","title":"MiR-19a Affects Hepatocyte Autophagy via Regulating lncRNA NBR2 and AMPK/PPARα in D-GalN/Lipopolysaccharide-Stimulated Hepatocytes.","date":"2017","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/28586153","citation_count":21,"is_preprint":false},{"pmid":"31077206","id":"PMC_31077206","title":"Apolipoprotein A5 alleviates LPS/D-GalN-induced fulminant liver failure in mice by inhibiting TLR4-mediated NF-κB pathway.","date":"2019","source":"Journal of translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/31077206","citation_count":20,"is_preprint":false},{"pmid":"24692489","id":"PMC_24692489","title":"Whole-mount X-Gal staining of mouse tissues.","date":"2014","source":"Cold Spring Harbor protocols","url":"https://pubmed.ncbi.nlm.nih.gov/24692489","citation_count":20,"is_preprint":false},{"pmid":"10391993","id":"PMC_10391993","title":"alpha-Gal epitopes in animal tissue glycoproteins and glycolipids.","date":"1999","source":"Sub-cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10391993","citation_count":19,"is_preprint":false},{"pmid":"36764278","id":"PMC_36764278","title":"The novel hepatoprotective mechanisms of silibinin-phospholipid complex against d-GalN/LPS-induced acute liver injury.","date":"2023","source":"International immunopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/36764278","citation_count":19,"is_preprint":false},{"pmid":"11740394","id":"PMC_11740394","title":"The structure of anti-Gal immunoglobulin genes in naïve and stimulated Gal knockout mice.","date":"2001","source":"Transplantation","url":"https://pubmed.ncbi.nlm.nih.gov/11740394","citation_count":19,"is_preprint":false},{"pmid":"37224271","id":"PMC_37224271","title":"Engineering an Efficient Expression Using Heterologous GAL Promoters and Transcriptional Activators in Saccharomyces cerevisiae.","date":"2023","source":"ACS synthetic biology","url":"https://pubmed.ncbi.nlm.nih.gov/37224271","citation_count":18,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":51134,"output_tokens":3146,"usd":0.100296,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":10604,"output_tokens":3465,"usd":0.069822,"stage2_stop_reason":"end_turn"},"total_usd":0.170118,"stage1_batch_id":"msgbatch_01DUPACZi7AAWwuZiUjseQF4","stage2_batch_id":"msgbatch_018yt7chE3f48PEFtDwtj6AE","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1999,\n      \"finding\": \"GMAP-210 (encoded by TRIP11/GAL-GMAP locus) is a direct microtubule-binding protein that associates with a subpopulation of stable microtubules in situ. The COOH terminus binds microtubule ends while the NH2 terminus binds Golgi membranes, linking the cis-Golgi network to the minus ends of centrosome-nucleated microtubules. Overexpression induced dramatic Golgi enlargement and microtubule network perturbation, effects that required the COOH-terminal domain.\",\n      \"method\": \"In vitro microtubule-binding assay, deletion analysis, GFP-fusion overexpression, biochemical fractionation\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — direct in vitro reconstitution of microtubule binding, deletion mutagenesis mapping domains, confirmed by overexpression phenotype and GFP localization\",\n      \"pmids\": [\"10189370\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Overexpression of GMAP-210 blocks both anterograde ER-to-Golgi transport (of soluble alkaline phosphatase and membrane hemagglutinin) and retrograde Golgi-to-ER transport (Shiga toxin B-subunit), causing Golgi disassembly and accumulation of Golgi proteins in vesicle clusters throughout the cell.\",\n      \"method\": \"Overexpression, transport assays (anterograde and retrograde cargo), immunofluorescence, ultrastructural analysis\",\n      \"journal\": \"Traffic (Copenhagen, Denmark)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple cargo assays in one lab, overexpression approach (potential artifact), no rescue experiment\",\n      \"pmids\": [\"12383348\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"GMAP-210 recruits gamma-tubulin-containing complexes to cis-Golgi membranes independently of microtubule polymerization and of Golgi localization. Depletion by RNAi causes extensive Golgi fragmentation. Targeting the C-terminus to mitochondria redirects gamma-tubulin to mitochondrial surfaces and redistributes mitochondria to a pericentrosomal location, indicating microtubule-anchoring activity.\",\n      \"method\": \"RNA interference (RNAi) knockdown, overexpression/targeting to mitochondria, immunofluorescence for gamma-tubulin, microtubule polymerization inhibition assays\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — RNAi loss-of-function with clear Golgi fragmentation phenotype plus gain-of-function retargeting experiment, replicated across multiple conditions in a high-impact venue\",\n      \"pmids\": [\"15294158\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Loss-of-function mutations in TRIP11 (encoding GMAP-210) cause lethal skeletal dysplasia (achondrogenesis type 1A) in mice and humans. GMAP-210-deficient chondrocytes show disturbed Golgi architecture, altered Golgi-mediated glycosylation, and intracellular accumulation of perlecan (but not collagen II or aggrecan), demonstrating that GMAP-210 is required for efficient glycosylation and cellular transport of select extracellular matrix proteins.\",\n      \"method\": \"Positional cloning, nonsense mutation identification, glycosylation assays in fibroblasts/chondrocytes, immunostaining for perlecan/collagen II/aggrecan, human patient sequencing\",\n      \"journal\": \"The New England journal of medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic loss-of-function in mouse and replicated in 10 human patients, with biochemical glycosylation assays and cargo-specific trafficking phenotype\",\n      \"pmids\": [\"20089971\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"GMAP-210 is required for efficient anterograde trafficking at both the ERGIC and the Golgi complex, and for retrograde trafficking to the ER. Co-depletion experiments showed GMAP-210 acts partially redundantly with golgin GM130 for efficient anterograde cargo delivery to the cis-Golgi.\",\n      \"method\": \"Knockdown (siRNA), anterograde/retrograde transport assays, co-depletion with GM130\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple transport assays and co-depletion epistasis in a single lab, replicates and extends earlier trafficking findings\",\n      \"pmids\": [\"25717001\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Drosophila GMAP (the ortholog of mammalian GMAP-210/TRIP11) contains a LIR motif that mediates direct interaction with Atg8a (LC3 ortholog). GMAP LIR mutant flies accumulate Golgi markers and display elongated Golgi morphology, indicating that GMAP mediates selective autophagy (Golgiphagy) to regulate Golgi morphology and size.\",\n      \"method\": \"Quantitative proteomics in Atg8a-LDS mutants, LIR motif identification, GMAP LIR mutant fly generation, Golgi marker imaging\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — proteomics identification followed by genetic LIR mutant validation with clear Golgi morphology phenotype; Drosophila ortholog, single lab\",\n      \"pmids\": [\"35649355\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"GAL/GMAP immunoreactive fibers in the hippocampal formation and cortex are predominantly co-localized with dopamine beta-hydroxylase (noradrenergic marker). Treatment with 6-hydroxydopamine abolished all fibers in which GAL/GMAP and DBH co-existed, and reserpine caused marked GAL depletion, establishing that the majority of GAL/GMAP peptide in these regions is contained in noradrenergic terminals originating from the locus coeruleus.\",\n      \"method\": \"Immunofluorescence double-staining, 6-OHDA lesion, reserpine treatment\",\n      \"journal\": \"The Journal of comparative neurology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — lesion and pharmacological depletion experiments with immunohistochemistry confirming noradrenergic co-localization of GAL/GMAP\",\n      \"pmids\": [\"9512271\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"Leukemia inhibitory factor (LIF) is required for the upregulation of GAL and GMAP in dorsal root ganglion neurons following peripheral axotomy. LIF-deficient mice showed a 65–70% reduction in GAL/GMAP-immunoreactive DRG neuron profiles after sciatic nerve section compared to wild-type mice, identifying LIF as a key upstream regulator of injury-induced galanin/GMAP expression.\",\n      \"method\": \"Sciatic nerve axotomy in LIF-knockout and wild-type mice, immunofluorescence quantification of GAL/GMAP-positive neuron profiles\",\n      \"journal\": \"Experimental brain research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic knockout model with quantitative immunohistochemical readout, single lab\",\n      \"pmids\": [\"8951409\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"Intrathecal GMAP facilitates the baseline flexor reflex and blocks C-fiber conditioning stimulation-induced facilitation in rats with intact sciatic nerves. GMAP selectively antagonizes the reflex-facilitatory effect of substance P but not VIP. After sciatic nerve axotomy, GMAP expression is upregulated in ipsilateral DRG neurons and the blocking effect of GMAP on C-fiber-induced facilitation is significantly reduced, while the SP antagonism is lost and a VIP antagonism appears.\",\n      \"method\": \"Intrathecal peptide administration, flexor reflex electrophysiology, sciatic nerve section, immunohistochemistry\",\n      \"journal\": \"Neuropeptides\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo pharmacological and electrophysiological assays combined with axotomy model; single lab\",\n      \"pmids\": [\"7603589\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"Systemic resiniferatoxin (RTX) treatment upregulates GMAP (galanin message-associated peptide) mRNA and immunoreactivity in lumbar DRG neurons, paralleling upregulation of VIP and NOS, demonstrating that capsaicin-sensitive sensory neurons regulate GMAP expression in response to neurotoxic challenge (messenger plasticity).\",\n      \"method\": \"In situ hybridization for GMAP mRNA, immunohistochemistry, subcutaneous RTX injection\",\n      \"journal\": \"Neuroreport\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single lab, correlation between toxin treatment and mRNA/peptide upregulation, no direct mechanistic dissection\",\n      \"pmids\": [\"8595209\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"The galanin Gal1 receptor (Gal1R) forms functional heterotetramers with µ-opioid receptors (MOR). Within the MOR-Gal1R heterotetramer, heteromerization-dependent changes in the Gal1R homodimeric interface cause a switch in G-protein coupling from inhibitory Gi to stimulatory Gs proteins, while the MOR homodimer remains coupled to Gi, enabling canonical Gs-Gi antagonism at the adenylyl cyclase level.\",\n      \"method\": \"Peptide-interfering approach, total internal reflection fluorescence microscopy, co-immunoprecipitation, BRET/FRET biophysical assays, cAMP assays\",\n      \"journal\": \"Pharmacological research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple biophysical and biochemical methods in a single lab; novel mechanistic finding about G-protein coupling switch upon heterotetramerization\",\n      \"pmids\": [\"35750299\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"GMAP-210 (encoded by TRIP11, a product of the GAL/GAL-GMAP locus) is a cis-Golgi-associated coiled-coil protein whose NH2-terminus anchors it to Golgi membranes and whose COOH-terminus binds microtubule minus ends and recruits gamma-tubulin complexes, thereby tethering the cis-Golgi network to centrosome-nucleated microtubules, maintaining Golgi ribbon integrity, supporting bidirectional ER-Golgi vesicular trafficking, and regulating Golgi turnover via a LIR-motif-dependent selective autophagy interaction with Atg8/LC3; loss-of-function mutations cause achondrogenesis type 1A due to impaired glycosylation and selective intracellular cargo accumulation in chondrocytes; the GAL/GMAP neuropeptide precursor co-localizes with noradrenergic neurons in the locus coeruleus and hippocampal terminals, is upregulated after peripheral axotomy via LIF signaling, modulates spinal nociceptive transmission, and its receptor Gal1R can switch G-protein coupling from Gi to Gs upon forming heterotetramers with µ-opioid receptors.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"The GAL/GMAP locus is bicistronic in function within this corpus, encoding both the Golgi-associated coiled-coil protein GMAP-210 (TRIP11) and the galanin/GMAP neuropeptide precursor [#0, #6]. GMAP-210 is a microtubule-binding protein that tethers the cis-Golgi network to centrosome-nucleated microtubules: its COOH-terminus binds microtubule minus ends while its NH2-terminus anchors to Golgi membranes, and the C-terminus recruits gamma-tubulin complexes to Golgi membranes independently of microtubule polymerization [#0, #2]. Through this anchoring it maintains Golgi ribbon integrity—depletion fragments the Golgi while overexpression enlarges and disassembles it—and supports bidirectional ER-Golgi vesicular trafficking, acting partially redundantly with GM130 for anterograde cargo delivery to the cis-Golgi [#1, #2, #4]. A LIR motif in GMAP mediates direct interaction with Atg8/LC3 to drive selective autophagy of the Golgi (Golgiphagy), regulating Golgi size and morphology [#5]. Loss-of-function mutations in TRIP11 cause achondrogenesis type 1A, with chondrocytes showing disturbed Golgi architecture, altered glycosylation, and selective intracellular accumulation of perlecan [#3]. Separately, the galanin/GMAP neuropeptide is concentrated in noradrenergic locus coeruleus terminals projecting to hippocampus and cortex, is upregulated in sensory neurons after peripheral axotomy via LIF signaling, and modulates spinal nociceptive transmission [#6, #7, #8]; its receptor Gal1R switches G-protein coupling from Gi to Gs upon forming heterotetramers with µ-opioid receptors [#10].\",\n  \"teleology\": [\n    {\n      \"year\": 1999,\n      \"claim\": \"Established the core biochemical activity of GMAP-210 by showing it physically bridges the cis-Golgi to microtubules, defining the molecular basis for Golgi positioning.\",\n      \"evidence\": \"In vitro microtubule-binding assay with deletion analysis and GFP-fusion overexpression\",\n      \"pmids\": [\"10189370\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Overexpression phenotype may not reflect endogenous stoichiometry\", \"Did not address how membrane and microtubule binding are coordinated in vivo\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Linked GMAP-210 dosage to vesicular transport by showing its overexpression blocks both anterograde and retrograde ER-Golgi traffic, implicating it in trafficking beyond static tethering.\",\n      \"evidence\": \"Overexpression with multiple cargo transport assays and ultrastructural analysis\",\n      \"pmids\": [\"12383348\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Overexpression approach risks dominant-negative artifact\", \"No rescue or loss-of-function complement\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Defined GMAP-210 as a microtubule-anchoring factor that recruits gamma-tubulin to the Golgi, explaining how it nucleates/anchors microtubules at the Golgi surface; RNAi depletion confirmed it is required for Golgi integrity.\",\n      \"evidence\": \"RNAi knockdown plus gain-of-function mitochondrial retargeting with gamma-tubulin immunofluorescence\",\n      \"pmids\": [\"15294158\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct gamma-tubulin complex binding interface not mapped\", \"Relationship between gamma-tubulin recruitment and trafficking function unresolved\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Connected GMAP-210 loss to human disease, showing TRIP11 mutations cause achondrogenesis type 1A through Golgi-dependent glycosylation defects and cargo-selective trafficking failure.\",\n      \"evidence\": \"Positional cloning, mouse knockout, human patient sequencing, glycosylation and cargo-specific immunostaining assays\",\n      \"pmids\": [\"20089971\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Why perlecan but not collagen II/aggrecan is selectively retained is unexplained\", \"Mechanism linking Golgi architecture loss to glycosylation defect not detailed\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Refined GMAP-210's trafficking role by demonstrating it functions at both ERGIC and Golgi and acts redundantly with GM130, clarifying the network of golgins supporting cargo delivery.\",\n      \"evidence\": \"siRNA knockdown with co-depletion epistasis and transport assays\",\n      \"pmids\": [\"25717001\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Degree of functional overlap with other golgins not exhaustively tested\", \"Single-lab transport assays\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Identified a new regulatory mechanism for Golgi homeostasis by showing GMAP uses a LIR motif to drive selective autophagy of the Golgi (Golgiphagy).\",\n      \"evidence\": \"Atg8a-LDS proteomics and GMAP LIR mutant fly generation with Golgi marker imaging\",\n      \"pmids\": [\"35649355\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Demonstrated in Drosophila ortholog; mammalian conservation not shown in this corpus\", \"Trigger and physiological context of Golgiphagy unknown\"]\n    },\n    {\n      \"year\": 1996,\n      \"claim\": \"Identified LIF as an upstream regulator of injury-induced galanin/GMAP expression, framing the neuropeptide arm as part of a regulated nerve-injury response.\",\n      \"evidence\": \"Sciatic nerve axotomy in LIF-knockout vs wild-type mice with immunofluorescence quantification\",\n      \"pmids\": [\"8951409\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Downstream signaling from LIF to GAL/GMAP transcription not mapped\", \"Single-lab knockout model\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Localized the galanin/GMAP neuropeptide to noradrenergic locus coeruleus terminals in hippocampus and cortex, establishing its anatomical neurotransmitter context.\",\n      \"evidence\": \"Immunofluorescence double-staining with 6-OHDA lesion and reserpine depletion\",\n      \"pmids\": [\"9512271\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Functional consequence of co-release with noradrenaline not addressed\", \"Receptor mediating effects in these regions not identified here\"]\n    },\n    {\n      \"year\": 1995,\n      \"claim\": \"Characterized the GMAP neuropeptide's modulation of spinal nociception and its plasticity after nerve injury, showing it antagonizes substance P-driven reflex facilitation and shifts specificity after axotomy.\",\n      \"evidence\": \"Intrathecal peptide administration, flexor reflex electrophysiology, axotomy and immunohistochemistry; plus RTX-induced mRNA/peptide upregulation by in situ hybridization\",\n      \"pmids\": [\"7603589\", \"8595209\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Receptor mediating GMAP's spinal effects not identified\", \"RTX upregulation is correlative without mechanistic dissection\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Revealed that the galanin Gal1 receptor reverses its G-protein output by switching from Gi to Gs upon heterotetramerizing with µ-opioid receptors, providing a mechanism for galanin-opioid crosstalk.\",\n      \"evidence\": \"Peptide-interfering approach, TIRF microscopy, co-IP, BRET/FRET and cAMP assays\",\n      \"pmids\": [\"35750299\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Physiological/in vivo relevance of the coupling switch not established\", \"Single-lab biophysical characterization\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How the two distinct functional outputs of the GAL/GMAP locus—the Golgi-tethering GMAP-210 protein and the secreted galanin/GMAP neuropeptide—are co-regulated or whether they share any mechanistic interplay remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No corpus finding links the trafficking and neuropeptide functions mechanistically\", \"Conservation of Golgiphagy in mammals untested\", \"In vivo significance of Gal1R-MOR coupling switch unknown\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0008092\", \"supporting_discovery_ids\": [0, 2]},\n      {\"term_id\": \"GO:0060089\", \"supporting_discovery_ids\": [10]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005794\", \"supporting_discovery_ids\": [0, 1, 2]},\n      {\"term_id\": \"GO:0005815\", \"supporting_discovery_ids\": [0, 2]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-5653656\", \"supporting_discovery_ids\": [1, 4]},\n      {\"term_id\": \"R-HSA-9612973\", \"supporting_discovery_ids\": [5]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [10]}\n    ],\n    \"complexes\": [\"MOR-Gal1R heterotetramer\"],\n    \"partners\": [\"GM130\", \"Atg8a\", \"gamma-tubulin\", \"MOR\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":6,"faith_total":6,"faith_pct":100.0}}